Insulin Degludec API
Insulin degludec is an ultra-long-acting insulin analogue with a side-chain modification that promotes multi-hexamer formation. As a chain-modified polypeptide hormone used primarily as insulin, it is classified under tariff item 2937.12.00.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If imported in patient-ready injectable forms
Finished pharmaceutical forms are classified in heading 30.04.
If the modification is so extensive that it is not considered insulin
Highly modified analogues may fall under other polypeptide hormones.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Document the structural modification and demonstrate the product's primary use as a hormone
• Import as bulk API to maintain classification under Chapter 29
• Verify that the product meets Canadian pharmacopoeia standards for purity
Related Products under Tariff item 2937.12.00
Bovine Insulin Crystals
Bovine insulin crystals are a highly purified, crystalline form of insulin derived from bovine pancreas. As a natural polypeptide hormone, it falls under tariff item 2937.12.00, which covers insulin and its salts, including natural or synthetic reproductions.
Human Insulin (rDNA)
Recombinant human insulin produced via DNA technology is a synthetic reproduction of the natural hormone, structurally identical to human insulin. It is classified under tariff item 2937.12.00 as insulin, regardless of its method of production.
Insulin Aspart (NovoRapid)
Insulin aspart is a rapid-acting insulin analogue produced by recombinant DNA technology, with a single amino acid substitution compared to human insulin. As a structural analogue of insulin used primarily for its hormonal effect, it is classified under tariff item 2937.12.00.
Insulin Detemir (Levemir)
Insulin detemir is a soluble long-acting insulin analogue with a fatty acid modification that enables albumin binding. As a derivative of insulin used primarily as a basal hormone replacement, it is classified under tariff item 2937.12.00.
Insulin Glargine (Lantus)
Insulin glargine is a long-acting basal insulin analogue produced by recombinant DNA technology, modified for a prolonged release profile. As a derivative and structural analogue of insulin used primarily as a hormone, it is classified under tariff item 2937.12.00.
Insulin Glulisine (Apidra)
Insulin glulisine is an ultra-rapid-acting insulin analogue with glycine and lysine modifications at the B-chain. As a recombinant DNA-produced structural analogue used primarily as a polypeptide hormone, it is classified under tariff item 2937.12.00.